Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway

Hepatic fibrosis is a progressive consequence of injury to the liver cells. Liver fibrosis causes hepatic dysfunction and also plays a key role in the pathogenesis of other chronic ailments. Dehydrozingerone (DHZ) is a half-structural analogue of curcumin and is known to have several therapeutic ben...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmacology 2022-12, Vol.937, p.175366-175366, Article 175366
Hauptverfasser:	Sharma, Nidhi, Shaikh, Taslim B., Eedara, Abhisheik, Kuncha, Madhusudhana, Sistla, Ramakrishna, Andugulapati, Sai Balaji
Format:	Artikel
Sprache:	eng
Schlagworte:	Catalase Collagen Liver fibrosis Myeloperoxidase Neutrophil-elastase Phytochemicals
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!